MX1 and COVID-19: To investigate if the significant difference in number and activation status observed in pDC of asymptomatic and severe COVID-19 patients would mirror a different anti-viral state in these individuals, we analyzed in ex vivo PBMC derived from HD, CP-AS and CP the transcription of the classical ISG Mx1, and found a striking difference in its expression level (Fig 7A).